KM PHARMA SERVICES LTD

Company Registration Number:
14626449 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2024

Period of accounts

Start date: 30 January 2023

End date: 31 January 2024

KM PHARMA SERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 January 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

KM PHARMA SERVICES LTD

Company Information

for the Period Ended 31 January 2024




Director: Kareem Mohamed
Registered office: 27
Garsdale Crescent
Baildon
Shipley
England
BD17 6TQ
Company Registration Number: 14626449 (England and Wales)

KM PHARMA SERVICES LTD

Balance sheet

As at 31 January 2024


Notes

2024
£
Fixed assets
Intangible assets: 4 0
Tangible assets: 5 0
Total fixed assets: 0
Current assets
Stocks: 0
Debtors: 6 0
Cash at bank and in hand: 0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 7 ( 0 )
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Creditors: amounts falling due after more than one year: 8 ( 1,006 )
Provision for liabilities: ( 0 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): ( 1,006 )

The notes form part of these financial statements

KM PHARMA SERVICES LTD

Balance sheet continued

As at 31 January 2024


Notes

2024
£
Capital and reserves
Called up share capital: 1
Revaluation reserve: 9 0
Profit and loss account: ( 1,007 )
Shareholders funds: ( 1,006 )

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 13 April 2024
And Signed On Behalf Of The Board By:

Name: Kareem Mohamed
Status: Director

The notes form part of these financial statements

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Employees


    2024
    Average number of employees during the period 0

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 3. Off balance sheet disclosure

    No

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

4. Intangible assets

Other Total
Cost £ £
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 January 2024 - -
Amortisation
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 January 2024 - -
Net book value
Net book value at 31 January 2024 - -

n/a

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

5. Tangible assets

Office equipment Total
Cost £ £
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 January 2024 - -
Depreciation
Charge for year - -
On disposals - -
Other adjustments - -
At 31 January 2024 - -
Net book value
At 31 January 2024 - -

n/a

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

6. Debtors


2024
£
Trade debtors 0
Prepayments and accrued income 0
Other debtors 0
Total 0
Debtors due after more than one year: 0

n/a

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

7.Creditors: amounts falling due within one year note


2024
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Trade creditors 0
Taxation and social security 0
Accruals and deferred income 0
Other creditors 0
Total 0

n/a

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

8.Creditors: amounts falling due after more than one year


2024
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Other creditors 1,006
Total 1,006

Amount due is owed to Director due to company expenses

KM PHARMA SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

9. Revaluation reserve


2024
£
Surplus or deficit after revaluation 0
Balance at 31 January 2024 0

n/a